ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy
Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.
SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery
To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.
Genomic Tools for Psilocybe cubensis Propagation
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Comprehensive Analysis of Next-Generation Biologics
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies
Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.
Mapping Gene Expression Signatures in the Heart and Lungs of Patients with COVID-19
These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.